Maximus [MAXIMUS] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Maximus International Ltd. wins in 12 metrics, Neogen Chemicals Ltd. wins in 7 metrics, with 0 ties. Maximus International Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Maximus International Ltd. | Neogen Chemicals Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.33 | 222.22 | Maximus International Ltd. |
| Price-to-Book Ratio | 1.68 | 5.46 | Maximus International Ltd. |
| Debt-to-Equity Ratio | 31.78 | 141.47 | Maximus International Ltd. |
| PEG Ratio | -0.50 | -3.52 | Maximus International Ltd. |
| EV/EBITDA | 11.76 | 42.55 | Maximus International Ltd. |
| Profit Margin (TTM) | 5.24% | 2.41% | Maximus International Ltd. |
| Operating Margin (TTM) | 6.14% | 11.39% | Neogen Chemicals Ltd. |
| EBITDA Margin (TTM) | 6.14% | 11.39% | Neogen Chemicals Ltd. |
| Return on Equity | 11.21% | 4.41% | Maximus International Ltd. |
| Return on Assets (TTM) | 7.00% | 1.99% | Maximus International Ltd. |
| Free Cash Flow (TTM) | $-201.80M | $-1.22B | Maximus International Ltd. |
| Dividend Yield | N/A | 0.19% | N/A |
| 1-Year Return | -8.76% | 10.59% | Neogen Chemicals Ltd. |
| Price-to-Sales Ratio (TTM) | 0.75 | 5.56 | Maximus International Ltd. |
| Enterprise Value | $1.61B | $53.55B | Neogen Chemicals Ltd. |
| EV/Revenue Ratio | 0.92 | 6.55 | Maximus International Ltd. |
| Gross Profit Margin (TTM) | 16.86% | 47.11% | Neogen Chemicals Ltd. |
| Revenue per Share (TTM) | $13 | $310 | Neogen Chemicals Ltd. |
| Earnings per Share (Diluted) | $0.67 | $7.47 | Neogen Chemicals Ltd. |
| Beta (Stock Volatility) | -0.51 | 0.22 | Maximus International Ltd. |
Maximus International Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Maximus International Ltd. | 0.29% | -0.57% | 4.82% | 14.85% | -7.69% | -5.00% |
| Neogen Chemicals Ltd. | -0.96% | 6.97% | 12.71% | 39.41% | 74.21% | 61.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Maximus International Ltd. | -8.76% | -35.22% | -89.30% | -16.31% | -16.31% | -16.31% |
| Neogen Chemicals Ltd. | 10.59% | 19.04% | 106.75% | 609.06% | 609.06% | 609.06% |
Performance & Financial Health Analysis: Maximus International Ltd. vs Neogen Chemicals Ltd.
| Metric | MAXIMUS | NEOGEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.33B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 26,548 | 170,744 |
| 90 Day Avg. Volume | 158,087 | 127,390 |
| Last Close | ₹10.47 | ₹1,882.90 |
| 52 Week Range | ₹8.00 - ₹13.00 | ₹966.70 - ₹1,960.30 |
| % from 52W High | -19.46% | -3.95% |
| All-Time High | ₹476.25 (Sep 19, 2022) | ₹2,420.00 (Dec 09, 2024) |
| % from All-Time High | -97.80% | -22.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.09% |
| Quarterly Earnings Growth | -0.30% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.02% |
| Operating Margin (TTM) | 0.06% | 0.11% |
| Return on Equity (TTM) | 0.11% | 0.04% |
| Debt to Equity (MRQ) | 31.78 | 141.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.71 | ₹303.78 |
| Cash per Share (MRQ) | ₹0.34 | ₹57.58 |
| Operating Cash Flow (TTM) | ₹-325,211,000 | ₹645.50M |
| Levered Free Cash Flow (TTM) | ₹90.58M | ₹348.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.19% |
| Last 12-Month Dividend | N/A | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Maximus International Ltd. vs Neogen Chemicals Ltd.
| Metric | MAXIMUS (Apr 24, 2026) | NEOGEN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.33 | 222.22 |
| Forward P/E | N/A | 72.26 |
| PEG Ratio | -0.50 | -3.52 |
| Price to Sales (TTM) | 0.75 | 5.56 |
| Price to Book (MRQ) | 1.68 | 5.46 |
| Market Capitalization | ||
| Market Capitalization | ₹1.33B | ₹44.76B |
| Enterprise Value | ₹1.61B | ₹53.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.92 | 6.55 |
| Enterprise to EBITDA | 11.76 | 42.55 |
| Risk & Other Metrics | ||
| Beta | -0.51 | 0.22 |
| Book Value per Share (MRQ) | ₹5.71 | ₹303.78 |
Financial Statements Comparison: Maximus International Ltd. vs Neogen Chemicals Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MAXIMUS (2025) | NEOGEN (2025) |
|---|---|---|
| Revenue/Sales | 1.56B | 7.58B |
| Cost of Goods Sold | 1.29B | 4.44B |
| COGS % of Revenue | 82.2% | 58.6% |
| Gross Profit | 277.64M | 3.13B |
| Gross Margin | 17.8% | 41.4% |
| Research & Development | N/A | 11.50M |
| Operating Income (EBIT) | 121.66M | 1.09B |
| Operating Margin | 7.8% | 14.4% |
| EBITDA | 147.20M | 1.31B |
| EBITDA Margin | 9.4% | 17.3% |
| Pre-Tax Income | 103.43M | 501.60M |
| Pre-Tax Income % of Revenue | 6.6% | 6.6% |
| Income Tax | 12.46M | 153.30M |
| Income Tax % of Revenue | 0.8% | 2.0% |
| Net Income (Profit) | 90.97M | 348.30M |
| Profit Margin | 5.8% | 4.6% |
Balance Sheet & Liquidity Metrics
| Metric | MAXIMUS (2025) | NEOGEN (2025) |
|---|---|---|
| Cash & Equivalents | 18.37M | 49.60M |
| Total Current Assets | 1.09B | 10.00B |
| Total Current Assets % of Revenue | 69.5% | 132.0% |
| Total Current Liabilities | 461.11M | 7.33B |
| Total Current Liabilities % of Revenue | 29.5% | 96.8% |
| Long-Term Debt | 46.71M | 1.94B |
| Long-Term Debt % of Revenue | 3.0% | 25.6% |
| Total Shareholders Equity | 808.10M | 7.89B |
| Retained Earnings | 355.91M | 2.28B |
| Retained Earnings % of Revenue | 22.8% | 30.1% |
| Property, Plant & Equipment | 63.28M | 890.30M |
Cash Flow Statement Comparison
| Metric | MAXIMUS (2025) | NEOGEN (2025) |
|---|---|---|
| Operating Cash Flow | -325.21M | 645.50M |
| Operating Cash Flow % of Revenue | -20.8% | 8.5% |
| Capital Expenditures | -53.06M | -3.17B |
| Free Cash Flow | -201.80M | -1.22B |
| FCF Margin | -12.9% | -16.1% |
| Debt Repayment | N/A | -718.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MAXIMUS | NEOGEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 136.04M | 27.38M |
| Float Shares | 41.31M | 13.28M |
| % Held by Insiders | 70.30% | 53.98% |
| % Held by Institutions | 1.29% | 23.81% |
| % Held by Public | 28.41% | 22.21% |
Dividend Analysis & Yield Comparison: Maximus International Ltd. vs Neogen Chemicals Ltd.
| Metric | MAXIMUS | NEOGEN |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹3.00 |
| Last 12-Month Dividend Yield | N/A | 0.19% |
| 3-Year Avg Annual Dividend | N/A | ₹2.00 |
| 3-Year Avg Dividend Yield | N/A | 0.11% |
| 3-Year Total Dividends | N/A | ₹6.00 |
| Ex-Dividend Date | N/A | Sep 19, 2025 |